These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 11774741)
1. Hammerhead ribozymes to modulate telomerase activity of endometrial carcinoma cells. Yokoyama Y; Wan X; Shinohara A; Takahashi Y; Tamaya T Hum Cell; 2001 Sep; 14(3):223-31. PubMed ID: 11774741 [TBL] [Abstract][Full Text] [Related]
2. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells. Hayashidani Y; Hiyama E; Murakami Y; Sueda T Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061 [TBL] [Abstract][Full Text] [Related]
4. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Yokoyama Y; Takahashi Y; Shinohara A; Lian Z; Wan X; Niwa K; Tamaya T Cancer Res; 1998 Dec; 58(23):5406-10. PubMed ID: 9850072 [TBL] [Abstract][Full Text] [Related]
5. [Attenuation of telomerase activity by hammerhead ribozyme targeting the 5'-end of hTERT mRNA]. Qu Y; Liu S; Liu B Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):389-92. PubMed ID: 12362313 [TBL] [Abstract][Full Text] [Related]
6. [Application of hammerhead ribozyme targeting telomerase molecule for cancer therapy]. Yokoyama Y; Takahashi Y; Shinohara A; Tamaya T Nihon Rinsho; 1998 May; 56(5):1126-30. PubMed ID: 9613108 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells. Yeo M; Rha SY; Jeung HC; Hu SX; Yang SH; Kim YS; An SW; Chung HC Int J Cancer; 2005 Apr; 114(3):484-9. PubMed ID: 15551309 [TBL] [Abstract][Full Text] [Related]
8. Divalent hammerhead ribozyme targeting template region of human telomerase RNA has potent cleavage activity, but less inhibitory activity on telomerase. Yokoyama Y; Wan X; Takahashi Y; Shinohara A; Liulin T; Tamaya T Arch Biochem Biophys; 2002 Sep; 405(1):32-7. PubMed ID: 12176054 [TBL] [Abstract][Full Text] [Related]
9. [Hammerhead ribozyme against human telomerase catalytic subunit (hTERT) induced apoptosis of liver cancer cells]. Song DP; Lin JS; Fu GL; Sun XM; Kong XJ; Li PY; Ma X Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):616-9. PubMed ID: 15504295 [TBL] [Abstract][Full Text] [Related]
10. [Inhibition of telomerase activity by ribozyme targeted to human telomerase transcriptase]. Qu Y; Liu SQ; Peng WZ; Liu BL Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):323-8. PubMed ID: 12019445 [TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398 [TBL] [Abstract][Full Text] [Related]
12. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487 [TBL] [Abstract][Full Text] [Related]
13. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript. Kwon BS; Jung HS; Song MS; Cho KS; Kim SC; Kimm K; Jeong JS; Kim IH; Lee SW Mol Ther; 2005 Nov; 12(5):824-34. PubMed ID: 16040278 [TBL] [Abstract][Full Text] [Related]
14. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo. Song MS; Jeong JS; Ban G; Lee JH; Won YS; Cho KS; Kim IH; Lee SW Cancer Gene Ther; 2009 Feb; 16(2):113-25. PubMed ID: 18758435 [TBL] [Abstract][Full Text] [Related]
15. Non-enzymatic in vitro production of circular hammerhead ribozyme targeting the template region of human telomerase RNA. Ochi A; Umekage S; Kikuchi Y Nucleic Acids Symp Ser (Oxf); 2009; (53):275-6. PubMed ID: 19749367 [TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma. Li Y; Li M; Yao G; Geng N; Xie Y; Feng Y; Zhang P; Kong X; Xue J; Cheng S; Zhou J; Xiao L Cancer Gene Ther; 2011 May; 18(5):318-25. PubMed ID: 21233858 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of telomerase RNA using hammerhead ribozymes and RNA interference. Li S; Nosrati M; Kashani-Sabet M Methods Mol Biol; 2007; 405():113-31. PubMed ID: 18369821 [TBL] [Abstract][Full Text] [Related]
18. Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme. Song MS; Jeong JS; Cho KS; Lee SW Exp Mol Med; 2007 Dec; 39(6):722-32. PubMed ID: 18160843 [TBL] [Abstract][Full Text] [Related]
19. [Construction and screening of a ribozyme targeting telomerase RNA and effects of telomerase ribozyme on proliferation and apoptosis of CNE-2Z cells]. Zhao YH; Chen XY; R Arrand J Ai Zheng; 2004 Jan; 23(1):50-5. PubMed ID: 14720374 [TBL] [Abstract][Full Text] [Related]
20. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells. Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]